Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study

The poor quality of life associated with the loss of teeth can be improved by the placing of dental implants. However, successful implantation relies on integration with soft tissues or peri-implant inflammatory disease that can lead to the loss of the implant. Pharmacological agents, such as antibi...

Full description

Bibliographic Details
Main Authors: John Xiong, Catherine M. Miller, Dileep Sharma
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Functional Biomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4983/14/9/474
_version_ 1797579361519403008
author John Xiong
Catherine M. Miller
Dileep Sharma
author_facet John Xiong
Catherine M. Miller
Dileep Sharma
author_sort John Xiong
collection DOAJ
description The poor quality of life associated with the loss of teeth can be improved by the placing of dental implants. However, successful implantation relies on integration with soft tissues or peri-implant inflammatory disease that can lead to the loss of the implant. Pharmacological agents, such as antibiotics and antiseptics, can be used as adjunct therapies to facilitate osseointegration; however, they can have a detrimental effect on cells, and resistance is an issue. Alternative treatments are needed. Hence, this study aimed to examine the safety profile of bergenin (at 2.5 μM and 5 μM), a traditional medicine, towards human gingival fibroblasts cultured on acid-etched zirconia implant surfaces. Cellular responses were analysed using SEM, resazurin assay, and scratch wound healing assay. Qualitative assessment was conducted for morphology (day 1) and attachment (early and delayed), and quantitative evaluation for proliferation (day 1, 3, 5 and 7), and migration (0 h, 6 h and 24 h). The concentrations of bergenin at 2.5 μM and 5 μM did not demonstrate a statistically significant effect with regard to any of the cellular responses (<i>p</i> > 0.05) tested. In conclusion, bergenin is non-cytotoxic and is potentially safe to be used as a local pharmacological agent for the management of peri-implant inflammatory diseases.
first_indexed 2024-03-10T22:36:04Z
format Article
id doaj.art-3aabc63035c44592b9d72920a4aa9978
institution Directory Open Access Journal
issn 2079-4983
language English
last_indexed 2024-03-10T22:36:04Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Journal of Functional Biomaterials
spelling doaj.art-3aabc63035c44592b9d72920a4aa99782023-11-19T11:23:35ZengMDPI AGJournal of Functional Biomaterials2079-49832023-09-0114947410.3390/jfb14090474Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro StudyJohn Xiong0Catherine M. Miller1Dileep Sharma2College of Medicine and Dentistry, James Cook University, Smithfield, QLD 4878, AustraliaCollege of Medicine and Dentistry, James Cook University, Smithfield, QLD 4878, AustraliaCollege of Medicine and Dentistry, James Cook University, Smithfield, QLD 4878, AustraliaThe poor quality of life associated with the loss of teeth can be improved by the placing of dental implants. However, successful implantation relies on integration with soft tissues or peri-implant inflammatory disease that can lead to the loss of the implant. Pharmacological agents, such as antibiotics and antiseptics, can be used as adjunct therapies to facilitate osseointegration; however, they can have a detrimental effect on cells, and resistance is an issue. Alternative treatments are needed. Hence, this study aimed to examine the safety profile of bergenin (at 2.5 μM and 5 μM), a traditional medicine, towards human gingival fibroblasts cultured on acid-etched zirconia implant surfaces. Cellular responses were analysed using SEM, resazurin assay, and scratch wound healing assay. Qualitative assessment was conducted for morphology (day 1) and attachment (early and delayed), and quantitative evaluation for proliferation (day 1, 3, 5 and 7), and migration (0 h, 6 h and 24 h). The concentrations of bergenin at 2.5 μM and 5 μM did not demonstrate a statistically significant effect with regard to any of the cellular responses (<i>p</i> > 0.05) tested. In conclusion, bergenin is non-cytotoxic and is potentially safe to be used as a local pharmacological agent for the management of peri-implant inflammatory diseases.https://www.mdpi.com/2079-4983/14/9/474zirconiadental implantfibroblastsbergenin
spellingShingle John Xiong
Catherine M. Miller
Dileep Sharma
Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
Journal of Functional Biomaterials
zirconia
dental implant
fibroblasts
bergenin
title Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
title_full Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
title_fullStr Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
title_full_unstemmed Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
title_short Effect of Bergenin on Human Gingival Fibroblast Response on Zirconia Implant Surfaces: An In Vitro Study
title_sort effect of bergenin on human gingival fibroblast response on zirconia implant surfaces an in vitro study
topic zirconia
dental implant
fibroblasts
bergenin
url https://www.mdpi.com/2079-4983/14/9/474
work_keys_str_mv AT johnxiong effectofbergeninonhumangingivalfibroblastresponseonzirconiaimplantsurfacesaninvitrostudy
AT catherinemmiller effectofbergeninonhumangingivalfibroblastresponseonzirconiaimplantsurfacesaninvitrostudy
AT dileepsharma effectofbergeninonhumangingivalfibroblastresponseonzirconiaimplantsurfacesaninvitrostudy